Inhibition of transcription of supercoiled PM2 DNA by carbodiimide modification.
PM2 superhelican DNA (form I), which as been reacted with the single strand specific reagent, N-cyclohexyl-N'-beta-(methylmorpholinium)ethyl carbodiimide (CMC) is more than 95% inhibited in its ability to support transcription with E. coli B RNA polymerase in vitro. Almost complete inhibition of transcription was achieved after 2 hours of reaction with FI when only 1% of the bases were modified. A large increase in S20,* (from 26.8 S to 33.6 S) of FI DNA was observed during the course of reaction. Rifampicin resistant transcription is more susceptible to inhibition by CMC than total transcription, suggesting that the CMC is preferentially binding at promoter sites. These results clearly are in accord with the observation that supercoiled DNA contains localized regions of unpaired bases. The promotor sites for E. coli RNA polymerase in FI PM2 DNA appear to be located at or near these unpaired sites.
D002234:Carbodiimides / Q000494:pharmacology*; D002499:Centrifugation, Density Gradient; D004279:DNA, Viral / Q000378:metabolism*; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D004926:Escherichia coli; D007700:Kinetics; D009025:Morpholines / Q000494:pharmacology; D009690:Nucleic Acid Conformation / Q000187:drug effects*; D012293:Rifampin / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects*; D014461:Ultracentrifugation
D002234:Carbodiimides; D004279:DNA, Viral; D009025:Morpholines; D012321:DNA-Directed RNA Polymerases; D012293:Rifampin